Astrazeneca Investment (China) Co Ltd Sustainability Reports
AstraZeneca Investment (China) Co., Ltd. engages in drug research, development, sales, marketing, and distribution activities within China. The company focuses on therapeutic areas such as oncology, respiratory, cardiovascular, renal, metabolic, and rare diseases.
Sector: Manufacturing
Country: China
Exchange: Unlisted
3 reports from 2022 to 2025
